Keshu Hu - Publications

Optimizing surgical timing following neoadjuvant therapy for gastric Cancer: Insights from a multicenter retrospective analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: December 22, 2024

Prostate cancer-associated transcript 6 (PCAT6) promotes epithelial-mesenchymal transition and stemness and worsens prognosis in patients with colorectal cancer.

Journal: Acta biochimica et biophysica Sinica

Published: April 12, 2024

Colorectal cancer with BRAF V600E mutation: Trends in immune checkpoint inhibitor treatment.

Journal: Critical reviews in oncology/hematology

Published: April 02, 2024

Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study.

Journal: Nature communications

Published: March 09, 2024

Sulfarotene Inhibits Colorectal Cancer via Mitigating Natural-Killer-Cell-Induced Stemness.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 09, 2024

IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophages.

Journal: Cell death & disease

Published: November 28, 2023

ScRNA-seq of gastric cancer tissues reveals differences in the immune microenvironment of primary tumors and metastases.

Journal: Oncogene

Published: August 17, 2023

JUNB mediates oxaliplatin resistance via the MAPK signaling pathway in gastric cancer by chromatin accessibility and transcriptomic analysis.

Journal: Acta biochimica et biophysica Sinica

Published: June 20, 2023

Negative correlation between acetyl-CoA acyltransferase 2 and cetuximab resistance in colorectal cancer.

Journal: Acta biochimica et biophysica Sinica

Published: June 13, 2023

Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment.

Journal: Cellular and molecular gastroenterology and hepatology

Published: April 07, 2022

An Immune-Related Gene Signature Predicting Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.

Journal: Combinatorial chemistry & high throughput screening

Published: August 24, 2021

Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.

Journal: Annals of translational medicine

Published: March 12, 2021